Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.59 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.59 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2530355 | 1.00 | ADORA3 (0.59) | ADORA3ADORA2AALDH1A1PMP22TP53 | |
| SCHEMBL10883918 | 1.00 | ADORA3 (0.59) | ADORA3ADORA2AALDH1A1PMP22TP53 | |
| SCHEMBL9275302 | 1.00 | ADORA3 (0.59) | ADORA3ADORA2AALDH1A1PMP22TP53 | |
| SCHEMBL63155 | 1.00 | ADORA3 (0.59) | ADORA3ADORA2AALDH1A1PMP22TP53 | |
| SCHEMBL10927483 | 1.00 | ADORA3 (0.59) | ADORA3ADORA2AALDH1A1PMP22TP53 | |
| SCHEMBL7893576 | 1.00 | ADORA3 (0.59) | ADORA3ADORA2AALDH1A1PMP22TP53 | |
| SCHEMBL10883899 | 1.00 | ADORA3 (0.59) | ADORA3ADORA2AALDH1A1PMP22TP53 | |
| SCHEMBL18503542 | 1.00 | ADORA3 (0.59) | ADORA3ADORA2AALDH1A1PMP22TP53 | |
| SCHEMBL18503560 | 0.91 | LMNA (0.59) | ALDH1A1PMP22TSHRNFKB1NPC1 | |
| SCHEMBL1572862 | 0.89 | ADORA3 (0.49) | ADORA3ADORA2AALDH1A1PMP22TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 478 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2640852-A1 | SIGNAL AMPLIFICATION | Speedx Pty Ltd (AU) | 2013-09-25 | — | — | EP | claimed |
| US-8394946-B2 | Multicomponent nucleic acid enzymes and methods for their use | SPEEDX PTY LTD (AU) | 2013-03-12 | — | — | US | claimed |
| WO-2012065231-A1 | SIGNAL AMPLIFICATION | SPEEDX PTY LTD (AU) | 2012-05-24 | — | — | WO | claimed |
| CN-101341260-A | Multi-component nucleases and methods of use thereof | JOHNSON & JOHNSON RES PTY LTD (AU) | 2009-01-07 | — | — | CN | claimed |
| EP-1948822-A1 | MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE | JOHNSON & JOHNSON RESEARCH PTY LIMITED (AU) | 2008-07-30 | — | — | EP | claimed |
| US-20070231810-A1 | Multicomponent nucleic acid enzymes and methods for their use | SPEEDX PTY LTD (AU) | 2007-10-04 | — | — | US | claimed |
| WO-2007041774-A1 | MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE | JOHNSON & JOHNSON RESEARCH PTY LIMITED (AU) | 2007-04-19 | — | — | WO | claimed |
| EP-0795029-A1 | CHEMICAL LABELLING OF OBJECTS | Pabio (NO) | 1997-09-17 | — | — | EP | claimed |
| WO-1996017954-A1 | CHEMICAL LABELLING OF OBJECTS | PABIO (DK) | 1996-06-13 | — | — | WO | claimed |
| WO-2026102473-A1 | TEMPERATURE DEPENDENT PROBES FOR TARGET DETECTION | SPEEDX PTY LTD (AU) | 2026-05-21 | — | — | WO | disclosed |
| EP-4731186-A2 | METHODS AND COMPOSITIONS FOR TREATING EPITHELIAL DISEASES | The Regents of the University of California (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260097121-A1 | Biallelic Knockout of CISH | EMENDOBIO INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260097123-A1 | Biallelic Knockout of CIITA | EMENDOBIO INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260085331-A1 | Biallelic Knockout of PDCD1 | EMENDOBIO INC (US) | 2026-03-26 | — | — | US | disclosed |
| US-6004754-A | METHODS AND NUCLEIC ACID SEQUENCES FOR IDENTIFYING STREPTOCOCCUS AGALACTIAE BY NUCLEIC ACID AMPLIFICATION AND NUCLEIC ACID HYBRIDIZATION | BECTON DICKINSON AND COMPANY (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0905259-A1 | Identification of a DNA region potentially useful for the detection of mycobacterium kansasii | Becton, Dickinson and Company (US) | 1999-03-31 | — | — | EP | disclosed |
| US-5821052-A | BINDS TO COMPLEMENTARY BASES OF TRANSFER RNA; INHIBITS TRANSLATION OF THE PROTEIN; FOR USE IN BACTERIA OR CELL-FREE SYSTEMS TO CONTROL SYNTHESIS OF A PROTEIN | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 1998-10-13 | — | — | US | disclosed |
| EP-0795029-A1 | CHEMICAL LABELLING OF OBJECTS | Pabio (NO) | 1997-09-17 | — | — | EP | disclosed |
| WO-1996017954-A1 | CHEMICAL LABELLING OF OBJECTS | PABIO (DK) | 1996-06-13 | — | — | WO | disclosed |
| US-5258284-A | Nucleic acid probes specific for pathogenic strains of vibrio vulnificus and method employing the same | UNIVERSITY OF MARYLAND, SCHOOL OF MEDICINE (US) | 1993-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097121-A1 | Biallelic Knockout of CISH | PBK, ZFP3, ZFR | ADORA3 3049/4885ADORA2A 4371/4885ALDH1A1 3614/4885 |
| US-20260097123-A1 | Biallelic Knockout of CIITA | IKZF1, IKZF3, PRDM9 | ADORA3 2007/4885ADORA2A 3251/4885ALDH1A1 2571/4885 |
| US-20260085331-A1 | Biallelic Knockout of PDCD1 | PDCD1, STING1, PBK | ADORA3 2284/4885ADORA2A 3578/4885ALDH1A1 2066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.